Furthermore, according to Lutz et al, elevated IL‐18 receptor signaling significantly reduces T‐cell mediated cytotoxicity, as tumor‐derived IL‐18 can lead to cytotoxic T‐cell exhaustion [62]. The gene discussed is IL18; the disease is neoplasm.